Suppr超能文献

早产和宫内炎症导致的围产期脑损伤:设计靶向干细胞疗法

Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies.

作者信息

Paton Madison C B, McDonald Courtney A, Allison Beth J, Fahey Michael C, Jenkin Graham, Miller Suzanne L

机构信息

Neurodevelopment and Neuroprotection Research Group, The Ritchie Centre, Hudson Institute of Medical Research, Monash UniversityClayton, VIC, Australia.

Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash UniversityClayton, VIC, Australia.

出版信息

Front Neurosci. 2017 Apr 10;11:200. doi: 10.3389/fnins.2017.00200. eCollection 2017.

Abstract

Chorioamnionitis is a major cause of preterm birth and brain injury. Bacterial invasion of the chorion and amnion, and/or the placenta, can lead to a fetal inflammatory response, which in turn has significant adverse consequences for the developing fetal brain. Accordingly, there is a strong causal link between chorioamnionitis, preterm brain injury and the pathogenesis of severe postnatal neurological deficits and cerebral palsy. Currently there are no treatments to protect or repair against brain injury in preterm infants born after pregnancy compromised by intrauterine infection. This review describes the injurious cascade of events in the preterm brain in response to a severe fetal inflammatory event. We will highlight specific periods of increased vulnerability, and the potential effects of therapeutic intervention with cell-based therapies. Many clinical trials are underway to investigate the efficacy of stem cells to treat patients with cerebral palsy. Stem cells, obtained from umbilical cord tissue and cord blood, normally discarded after birth, are emerging as a safe and potentially effective therapy. It is not yet known, however, which stem cell type(s) are the most efficacious for administration to preterm infants to treat brain injury-mediated inflammation. Individual stem cell populations found in cord blood and tissue, such as mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs), have a number of potential benefits that may specifically target preterm inflammatory-induced brain injury. MSCs have strong immunomodulatory potential, protecting against global and local neuroinflammatory cascades triggered during infection to the fetus. EPCs have angiogenic and vascular reparative qualities that make them ideal for neurovascular repair. A combined therapy using both MSCs and EPCs to target inflammation and promote angiogenesis for re-establishment of vital vessel networks is a treatment concept that warrants further investigation.

摘要

绒毛膜羊膜炎是早产和脑损伤的主要原因。细菌侵入绒毛膜、羊膜和/或胎盘会导致胎儿炎症反应,进而对发育中的胎儿大脑产生重大不良后果。因此,绒毛膜羊膜炎、早产脑损伤与严重产后神经功能缺损和脑瘫的发病机制之间存在密切的因果关系。目前,对于因宫内感染导致妊娠受损而出生的早产儿,尚无保护或修复脑损伤的治疗方法。本综述描述了早产脑对严重胎儿炎症事件的有害事件级联反应。我们将强调易损性增加的特定时期,以及基于细胞疗法的治疗干预的潜在效果。许多临床试验正在进行,以研究干细胞治疗脑瘫患者的疗效。从脐带组织和脐带血中获取的干细胞,通常在出生后被丢弃,正成为一种安全且可能有效的治疗方法。然而,尚不清楚哪种干细胞类型对治疗早产脑损伤介导的炎症最有效。在脐带血和组织中发现的单个干细胞群体,如间充质干细胞(MSCs)和内皮祖细胞(EPCs),具有许多潜在益处,可能专门针对早产炎症引起的脑损伤。间充质干细胞具有强大的免疫调节潜力,可防止感染胎儿期间引发的全身和局部神经炎症级联反应。内皮祖细胞具有血管生成和血管修复特性,使其成为神经血管修复的理想选择。使用间充质干细胞和内皮祖细胞联合治疗以靶向炎症并促进血管生成以重建重要血管网络是一个值得进一步研究的治疗概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/5385368/e362d09ae0ff/fnins-11-00200-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验